Rohto Pharmaceutical Co.,Ltd. (4527.T)
JPY 2418.5
(1.28%)
JPY 2418.5
(1.28%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 48.85 Billion JPY | 12.82% |
| 2022 | 41.33 Billion JPY | 13.46% |
| 2021 | 35.81 Billion JPY | 19.92% |
| 2020 | 28.61 Billion JPY | 8.76% |
| 2019 | 29.81 Billion JPY | 14.66% |
| 2018 | 27.21 Billion JPY | 2.47% |
| 2017 | 25 Billion JPY | 13.1% |
| 2016 | 21.37 Billion JPY | 0.31% |
| 2015 | 22.13 Billion JPY | 6.75% |
| 2014 | 19.5 Billion JPY | -11.82% |
| 2013 | 22.74 Billion JPY | 13.99% |
| 2012 | 19.25 Billion JPY | -31.45% |
| 2011 | 19.44 Billion JPY | 3.69% |
| 2010 | 18.24 Billion JPY | 0.56% |
| 2009 | 18.34 Billion JPY | 3.76% |
| 2008 | 15.4 Billion JPY | 0.84% |
| 2007 | 17.36 Billion JPY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 13.79 Billion JPY | 96.07% |
| 2023 Q4 | 7.16 Billion JPY | -56.5% |
| 2023 FY | - JPY | 12.82% |
| 2023 Q1 | 12.11 Billion JPY | 125.68% |
| 2023 Q2 | 10.77 Billion JPY | -11.11% |
| 2023 Q3 | 16.48 Billion JPY | 52.99% |
| 2022 Q1 | 9.37 Billion JPY | 67.16% |
| 2022 Q4 | 5.37 Billion JPY | -54.63% |
| 2022 Q3 | 11.83 Billion JPY | 32.75% |
| 2022 FY | - JPY | 13.46% |
| 2022 Q2 | 8.91 Billion JPY | -4.9% |
| 2021 Q2 | 7.88 Billion JPY | 19.03% |
| 2021 Q4 | 5.6 Billion JPY | -45.9% |
| 2021 Q3 | 10.36 Billion JPY | 31.43% |
| 2021 FY | - JPY | 19.92% |
| 2021 Q1 | 6.62 Billion JPY | -8.39% |
| 2020 FY | - JPY | 8.76% |
| 2020 Q1 | 4.26 Billion JPY | 2.67% |
| 2020 Q3 | 6.42 Billion JPY | -10.06% |
| 2020 Q2 | 7.14 Billion JPY | 67.39% |
| 2020 Q4 | 7.23 Billion JPY | 12.56% |
| 2019 Q2 | 6.99 Billion JPY | 76.69% |
| 2019 Q4 | 4.15 Billion JPY | -42.41% |
| 2019 FY | - JPY | 14.66% |
| 2019 Q1 | 3.95 Billion JPY | 185.22% |
| 2019 Q3 | 7.22 Billion JPY | 3.29% |
| 2018 Q3 | 6.53 Billion JPY | 11.11% |
| 2018 FY | - JPY | 2.47% |
| 2018 Q4 | 1.38 Billion JPY | -78.76% |
| 2018 Q2 | 5.87 Billion JPY | 10.49% |
| 2018 Q1 | 5.32 Billion JPY | 69.59% |
| 2017 Q3 | 7.03 Billion JPY | 35.35% |
| 2017 FY | - JPY | 13.1% |
| 2017 Q1 | 3.62 Billion JPY | 19.69% |
| 2017 Q4 | 3.13 Billion JPY | -55.38% |
| 2017 Q2 | 5.19 Billion JPY | 43.12% |
| 2016 Q2 | 4.42 Billion JPY | 79.5% |
| 2016 Q3 | 6.17 Billion JPY | 39.68% |
| 2016 Q4 | 3.03 Billion JPY | -50.92% |
| 2016 FY | - JPY | 0.31% |
| 2016 Q1 | 2.46 Billion JPY | -21.8% |
| 2015 FY | - JPY | 6.75% |
| 2015 Q4 | 3.15 Billion JPY | -33.73% |
| 2015 Q3 | 4.75 Billion JPY | -11.99% |
| 2015 Q2 | 5.4 Billion JPY | 146.26% |
| 2015 Q1 | 2.19 Billion JPY | -50.56% |
| 2014 Q4 | 4.43 Billion JPY | 9.36% |
| 2014 FY | - JPY | -11.82% |
| 2014 Q1 | 1.14 Billion JPY | -70.03% |
| 2014 Q2 | 4.58 Billion JPY | 300.09% |
| 2014 Q3 | 4.05 Billion JPY | -11.42% |
| 2013 Q4 | 3.82 Billion JPY | -33.39% |
| 2013 FY | - JPY | 13.99% |
| 2013 Q1 | 3.2 Billion JPY | -18.36% |
| 2013 Q2 | 4.63 Billion JPY | 44.49% |
| 2013 Q3 | 5.73 Billion JPY | 23.86% |
| 2012 Q1 | 2.93 Billion JPY | -77.67% |
| 2012 Q4 | 3.92 Billion JPY | -22.27% |
| 2012 Q2 | 3.09 Billion JPY | 5.31% |
| 2012 Q3 | 5.05 Billion JPY | 63.25% |
| 2012 FY | - JPY | -31.45% |
| 2011 Q2 | 3.59 Billion JPY | 18.08% |
| 2011 Q3 | 4.91 Billion JPY | 36.8% |
| 2011 Q4 | 13.15 Billion JPY | 167.75% |
| 2011 FY | - JPY | 3.69% |
| 2011 Q1 | 3.04 Billion JPY | -79.54% |
| 2010 FY | - JPY | 0.56% |
| 2010 Q1 | 3.38 Billion JPY | -76.61% |
| 2010 Q2 | 4.44 Billion JPY | 31.22% |
| 2010 Q3 | 6.04 Billion JPY | 35.89% |
| 2010 Q4 | 14.86 Billion JPY | 146.02% |
| 2009 Q2 | 3.93 Billion JPY | -14.68% |
| 2009 FY | - JPY | 3.76% |
| 2009 Q1 | 4.61 Billion JPY | -67.37% |
| 2009 Q4 | 14.48 Billion JPY | 160.69% |
| 2009 Q3 | 5.55 Billion JPY | 41.21% |
| 2008 Q3 | 5.89 Billion JPY | 102.09% |
| 2008 Q2 | 2.91 Billion JPY | 0.0% |
| 2008 Q4 | 14.13 Billion JPY | 139.67% |
| 2008 FY | - JPY | 0.84% |
| 2007 FY | - JPY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Kitanotatsujin Corporation | 1.58 Billion JPY | -2976.629% |
| Euglena Co., Ltd. | 676 Million JPY | -7126.923% |
| BEAUTY GARAGE Inc. | 1.96 Billion JPY | -2386.424% |
| Axas Holdings Co.,Ltd. | 555.75 Million JPY | -8690.517% |
| C.I. Medical Co.,Ltd. | 4.01 Billion JPY | -1117.393% |
| Kao Corporation | 154.49 Billion JPY | 68.379% |
| Niitaka Co., Ltd. | 1.36 Billion JPY | -3467.227% |
| Shiseido Company, Limited | 106.46 Billion JPY | 54.11% |
| Lion Corporation | 42.31 Billion JPY | -15.456% |
| Mandom Corporation | 6.69 Billion JPY | -629.273% |
| Ivy Cosmetics Corporation | 242.6 Million JPY | -20037.675% |
| Milbon Co., Ltd. | 7.8 Billion JPY | -526.3% |
| Nippon Shikizai, Inc. | 1.28 Billion JPY | -3691.317% |
| Fancl Corporation | 16.6 Billion JPY | -194.248% |
| KOSÉ Corporation | 26.85 Billion JPY | -81.904% |
| Cota Co., Ltd. | 2.26 Billion JPY | -2053.612% |
| HABA Laboratories,Inc. | -1.31 Billion JPY | 3817.083% |
| C'bon Cosmetics Co.,Ltd. | 171.84 Million JPY | -28328.777% |
| Pola Orbis Holdings Inc. | 23.17 Billion JPY | -110.787% |
| Noevir Holdings Co., Ltd. | 12.24 Billion JPY | -299.004% |
| Adjuvant Holdings Co.,Ltd. | 124 Million JPY | -39298.387% |
| Almado, Inc. | 983.21 Million JPY | -4868.786% |
| I-ne CO., LTD. | 4.7 Billion JPY | -939.447% |
| Premier Anti-Aging Co., Ltd. | -627 Million JPY | 7891.707% |
| Liberta Co.,Ltd. | 318.19 Million JPY | -15253.623% |
| AXXZIA Inc. | 1.28 Billion JPY | -3697.411% |
| S.T. Corporation | 2.62 Billion JPY | -1760.396% |
| Kobayashi Pharmaceutical Co., Ltd. | 31.68 Billion JPY | -54.191% |
| Earth Corporation | 10.6 Billion JPY | -360.539% |
| Sagami Rubber Industries Co., Ltd. | 1.09 Billion JPY | -4363.403% |
| Asahi Eito Holdings Co.,Ltd. | -573.98 Million JPY | 8611.432% |
| Ya-Man Ltd. | 1.43 Billion JPY | -3300.264% |
| MTG Co., Ltd. | 4.39 Billion JPY | -1011.834% |
| TRANSACTION CO.,Ltd. | 5.8 Billion JPY | -740.968% |
| SHOBIDO Corporation | 1.11 Billion JPY | -4300.484% |
| Artnature Inc. | 3.78 Billion JPY | -1190.045% |
| Pigeon Corporation | 15.8 Billion JPY | -209.085% |
| Unicharm Corporation | 178.01 Billion JPY | 72.557% |
| Paltac Corporation | 35.92 Billion JPY | -35.996% |
| CB GROUP MANAGEMENT Co., Ltd. | 3.28 Billion JPY | -1387.184% |